Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models

Những quyển sách tương tự

• Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts
  Bằng: Lieu, Christopher H., et al.
  Được phát hành: (2015)
• The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy
  Bằng: Greene, Justin, et al.
  Được phát hành: (2017)
• TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study
  Bằng: Bang, Yung-Jue, et al.
  Được phát hành: (2018)
• Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
  Bằng: Bagby, Stacey, et al.
  Được phát hành: (2016)
• Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer
  Bằng: Peter J. Klauck, et al.
  Được phát hành: (2018-02-01)